Laromustine

Laromustine
Trade Name Cloretazine
Orphan Indication Acute myeloid leukemia
USA Market Approval USA
USA Designation Date 2014-03-27 00:00:00
Sponsor Nanotherapeutics, Inc.;13859 Progress Blvd, Suite 300;Alachua, Florida, 32615